17 results
8-K
EX-3.2
OSIP
Osi Pharmaceuticals Inc
9 Jun 10
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
12:00am
8-K
EX-3.1
OSIP
Osi Pharmaceuticals Inc
9 Jun 10
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
12:00am
10-K
2008 FY
EX-3.2
OSIP
Osi Pharmaceuticals Inc
Annual report
27 Feb 09
12:00am
8-K
EX-3.2
OSIP
Osi Pharmaceuticals Inc
18 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-3.2
OSIP
Osi Pharmaceuticals Inc
17 Dec 07
OSI PHARMACEUTICALS ANNOUNCES LAUNCH DATE OF TARCEVA® (erlotinib) IN JAPAN
12:00am
8-K
EX-3
289d46da7wdurxfv
16 Jun 06
Encouraging Pre-Clinical Data From Diabetes/Obesity Program Also Presented
12:00am
10-K405
EX-3.1
6qwnf hsk
13 Dec 01
Annual report (delinquent filer disclosure)
12:00am
10-K405
EX-3.2
xrfi6v
13 Dec 01
Annual report (delinquent filer disclosure)
12:00am
8-A12G
EX-3
1g1y7lieapps9 04
27 Sep 00
Registration of securities
12:00am
S-3
EX-3.1
pxk1gji 7e
14 Feb 96
Shelf registration
12:00am
S-3
EX-3.2
o469krx3bnrwi
14 Feb 96
Shelf registration
12:00am
10-K
EX-3.2
ssq7ni7qz6nk4n8na
20 Dec 95
Annual report
12:00am
10-K
EX-3.1
00jec8thbaxwdph
20 Dec 95
Annual report
12:00am
- Prev
- 1
- Next